Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
GLP-1 medications may be contraindicated if you have or have a history of: personal and family history of papillary and follicular thyroid cancers (given that there may be an increased risk based on animal studies) chronic nausea, vomiting or gastroparesis (as GLP-1s slow down gastric emptying and may worsen GI symptoms) pancreatitis (GLP-1s may increase the risk of pancreatitis or inflammation of the pancreas) children under 12 years old currently pregnant or breastfeeding eating disorders allergy or hypersensitivity to the medication weight cycling (losing and gaining weight back) without needing to lose weight for health reasons Always consult a healthcare professional before starting GLP-1 medications to ensure they align with your health needs and treatment plan
The danger zone (above 86 degrees F) Above 86 degrees Fahrenheit (30 degrees Celsius), all bets are off
IDegLira is a combination of Novo Nordisks ultra-long acting insulin Tresiba (insulin degludec) and their GLP-1 agonist Victoza (liraglutide)
GLP-1 medications, or glucagon-like peptide-1 receptor agonists, mimic the bodys natural hormones to regulate glucose metabolism
.jpg)
